Terence Li
About Terence Li
Terence Li is the Vice President and Head of Clinical Operations at AffaMed Therapeutics, with over 15 years of experience in clinical research within the pharmaceutical and medical device sectors. He has held various leadership roles in organizations such as PPD, Servier, Alcon, and GE Healthcare, and has a strong academic background in clinical medicine from Peking University Health Science Center.
Work at AffaMed Therapeutics
Terence Li serves as the Vice President and Head of Clinical Operations at AffaMed Therapeutics. He has held this position since 2019, contributing to the company's clinical development strategies and overseeing clinical trial management. His role involves ensuring that clinical operations align with regulatory requirements and industry standards, facilitating the advancement of innovative therapies.
Previous Experience in Clinical Operations
Before joining AffaMed Therapeutics, Terence Li held several significant positions in clinical operations. He worked at GE Healthcare as the Head of Clinical Operations in China for six months in 2017. Prior to that, he served as Associate Director of Clinical Research and Clinical Project Management at Alcon, a Novartis company, from 2011 to 2017. His experience includes managing clinical trials and leading research initiatives in the pharmaceutical sector.
Education and Expertise
Terence Li has a solid educational foundation in clinical medicine. He studied at Peking University Health Science Center, where he completed a Dermatology Residency Program and earned a Master of Clinical Medicine from 1997 to 2004. His academic background supports his extensive expertise in clinical research, particularly within the pharmaceutical and medical device industries.
Career History in Clinical Research
Terence Li has over 15 years of experience in clinical research. His career includes roles at PPD as SPM/CM-SSU in Beijing from 2010 to 2011 and at Servier as Project Manager from 2004 to 2010. His diverse experience across various organizations has equipped him with strong skills in clinical trial management and clinical development.